Risks of a Range of Alcohol Intake on Hepatitis C-Related Fibrosis

Hepatology

Volumn 39, Issue 3, 2004, Pages 826-834

  Monto, Alexander ^a   Patel, Keyur ^a   Bostrom, Alan ^a   Pianko, Stephen ^a   Pockros, Paul ^a   McHutchison, John G ^a   Wright, Teresa L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL;

ADULT; AGE DISTRIBUTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ALCOHOLISM; ANALYTIC METHOD; ANAMNESIS; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL RATE;

AGING; ALANINE TRANSAMINASE; ALCOHOL DRINKING; BIOPSY; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; MULTIVARIATE ANALYSIS; RISK ASSESSMENT;

EID: 1542724807     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20127     Document Type: Article

References (32)

1. Wong JB, McQuillan GM, McHutchison JG, Poynard T. Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health 2000;90:1562-1569.
2. Prieto M, Berenguer M, Rimola A, Loinaz C, Barrios C, Clemente G, Figueras J, et al. Liver transplantation in hepatitis C: a Spanish multicenter experience. Eur J Gastroenterol Hepatol 1998;10:771-776.
3. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis in patients with chronic hepatitis C. Lancet 1997;349:825-832.
4. Roudot-Thoraval F, Bastie A, Pawlotsky J-M, Dhumeaux D. Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. HEPATOLOGY 1997;26:485-490.
5. Ostapowicz G, Watson KJ, Locarnini SA, Desmond PV. Role of alcohol in the progression of liver disease caused by hepatitis C virus infection. HEPATOLOGY 1998;27:1730-1735.
6. Yano M, Kumada H, Kage M, Ikeda K, Shimamatsu K, Inoue O, Hashimoto E, et al. The long-term pathological evolution of chronic hepatitis C. HEPATOLOGY 1996;23:1334-1340.
7. Gordon SC, Fang JWS, Silverman AL, McHutchison JG, Albrecht JK. The significance of baseline alanine aminotransferase on pretreatment disease characteristics and response to antiviral therapy in chronic hepatitis C. HEPATOLOGY 2000;32:400-404.
8. Freeman AJ, Dore GJ, Law MG, Thorpe M, Von Overbeck J, Lloyd AR, Marinos G, Kaldor JM. Estimating progression to cirrhosis in chronic hepatitis C virus infection. HEPATOLOGY 2001;34:809-816.
9. Seeff LB, Miller RN, Rabkin CS, Buskell-Bales Z, Straley-Eason KD, Smoak BL, Johnson LD, et al. 45-year follow-up of hepatitis C virus infection in healthy young adults. Ann Intern Med 2000;132:105-111.
10. National Institutes of Health Consensus Development Conference panel statement: management of hepatitis C. HEPATOLOGY 1997;26: 2S-10S.
11. Gronbaek M, Becker U, Johansen D, Gottschau A, Schnohr P, Hein HO, Jensen G, Sorensen TIA. Type of alcohol consumed and mortality from all causes, coronary heart disease, and cancer. Ann Intern Med 2000;133: 411-419.
12. Mukamal KJ, Conigrave KM, Mittleman MA, Camargo CA, Stampfer MJ, Willett WC, Rimm EB. Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med 2003;348:109-118.
13. Wiley TE, McCarthy M, Breidi L, McCarthy M, Layden TJ. Impact of alcohol on the histological and clinical progression of hepatitis C infection. HEPATOLOGY 1998;28:805-809.
14. Corrao G, Arico S. Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis. HEPATOLOGY 1998;27:914-919.
15. Harris DR, Gonin R, Alter HJ, Wright EC, Buskell ZJ, Hollinger FB, Seeff LB. The relationship of acute transfusion-associated hepatitis to the development of cirrhosis in the presence of alcohol abuse. Ann Intern Med 2001;134:120-124.
16. Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N, Nolt K, et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 2000;284:450-456.
17. Westin J, Lagging M, Spak F, Aires N, Svensson E, Lindh M, Dhillon AP, et al. Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection. J Viral Hepat 2002;9:235-241.
18. Williams GD, Proudfit AH, Quinn EA, Campbell KE. Variations in quantity-frequency measures of alcohol consumption from a general population survey. Addiction 1994;89:413-420.
19. McCullough AJ, O'Connor JFB. Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology. Am J Gastroenterol 1998;93:2022-2036.
20. Buchsbaum DG, Buchanan RG, Centor RM, Schnoll SH, Lawton MJ. Screening for alcohol abuse using CAGE scores and likelihood ratios. Ann Intern Med 1991;115:774-777.
21. Pol S, Fontaine H, Carnot F, Zylberberg H, Berthelot P, Brechot C, Nalpas B. Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: a comparison between immunocompetent and immunocompromised patients. J Hepatol 1998;29:12-19.
22. Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 1995;19:1409-1417.
23. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. HEPATOLOGY 1996;24:289-293.
24. Becker U, Deis A, Sorensen TI, Gronbaek M, Borch-Johnsen K, Florvall Muller C, Schnohr P, et al. Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. HEPATOLOGY 1996;23:1025-1029.
25. SAS, v. 8.2. Cary, NC: SAS Institute.
26. Marbet U, Bianchi L, Meury U, Stalder G. Long-term histological evaluation of the natural history and prognostic factors of alcoholic liver disease. J Hepatol 1987;4:364-372.
27. Shiffman ML, Stewart CA, Hofmann CM, Contos MJ, Luketic VA, Sterling RK, Sanyal AJ. Chronic infection with hepatitis C virus in patients with elevated or persistently normal serum alanine aminotransferase levels: comparison of hepatic histology and response to interferon therapy. J Infect Dis 2000;182:1595-1601.
28. Poynard T, Ratziu V, Charlotte F, Goodman Z, McHutchison JG, Albrecht J. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J Hepatol 2001;34:730-739.
29. Bonacini M, Groshen S, Yu MC, Govindarajan S, Lindsay KL. Chronic hepatitis C in ethnic minority patients evaluated in Los Angeles County. Am J Gastroenterol 2001;96:2438-2441.
30. Morgan MY, Sherlock S. Sex-related differences among 100 patients with alcoholic liver disease. Br Med J 1977;1:939-941.
31. Ashley MJ, Olin JS, le Riche WH, Kornaczewski A, Schmidt W, Rankin JG. Morbidity in alcoholics: evidence for accelerated development of physical disease in women. Arch Intern Med 1977;137:883-887.
32. Klatsky AL, Armstrong MA. Alcohol, smoking, coffee, and cirrhosis. Am J Epidemiol 1992;136:1248-1257.